---
title: "Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology"
description: "Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology"
---

[Resources - TD2 Precision Oncology ](https://td2inc.com/resources)

# [Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology](https://td2inc.com/resources/advancing-preclinical-cancer-research-through-metabolomics)

 Written by [TD2 Admin](https://td2inc.com/resources/author/td2-admin) | Jan 18, 2024 3:41:00 PM

The dynamic field of cancer research is continually evolving, driven by the pursuit of deeper understanding and novel therapeutic strategies against this multifaceted disease. Metabolomics, an emerging discipline, offers a wide-angle view of the metabolic shifts occurring in organisms. This article explores the application of metabolomics in preclinical cancer research, focusing on its critical role in the discovery of biomarkers, the assessment of therapeutic efficacy and safety, and the facilitation of drug-target mapping within the scope of immuno-oncology.

[View full post](https://td2inc.com/resources/advancing-preclinical-cancer-research-through-metabolomics)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "TD2 Admin"
  },
  "dateModified" : "2024-03-31T22:11:16.414Z",
  "datePublished" : "2024-01-18T15:41:00Z",
  "headline" : "Advancing Preclinical Cancer Research Through Metabolomics: Key Strategies for Biomarker Identification and Drug-Target Analysis in Immuno-Oncology",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1080,
    "url" : "https://22578525.fs1.hubspotusercontent-na1.net/hubfs/22578525/Assets/Images/global-metabolomics.png",
    "width" : 1500
  },
  "mainEntityOfPage" : "https://td2inc.com/resources/advancing-preclinical-cancer-research-through-metabolomics",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://22578525.fs1.hubspotusercontent-na1.net/hubfs/22578525/Assets/Logo/td2-logo.jpg",
      "width" : 106.1157
    },
    "name" : "Resources - TD2 Precision Oncology"
  }
}
```